Presentation of ESC Sample Clauses

Presentation of ESC. Within [**] days after Edison has identified, characterized and optimized any ESC under the Research Program, Edison shall provide written notice to Penwest and the GOC thereof and identifying the proposed markush group for such ESC. Additionally, Edison shall provide the GOC with all data and analysis necessary for the GOC to assess the ESC against the Development Criteria, as predetermined by the GOC. Such data shall include (a) data concerning such ESC’s concentration parameters, half life, pharmacological stability, oral bioavailability, preliminary toxicity panel and other efficacy criteria, and (b) preliminary information on freedom to operate from a Patent use or composition of matter perspective, manufacturability, stability, formulation, bioanalysis, pharmacology, toxicology and regulatory specifications, and shall present the ESC and its findings to Penwest for consideration. For the avoidance of doubt, Edison will not be obligated to use GLP in conducting the Research Program and will not be responsible for providing Penwest or the GOC with any GLP data with respect to any ESC. Without limiting Section 4.5, Edison shall not disclose or provide, or enter into any agreement granting any options or rights to, any ESC to a Third Party (i) during the period beginning on the Effective Date until the earlier of (A) Penwest’s selection of an ESC as a Future Compound pursuant to the provisions of Section 2.3.3, and (B) the later of [**] days after the expiration of (I) the Research Funding Period and (II) the occurrence of the Minimum ESC Requirement, or (ii) during the period commencing upon Edison’s receipt of Penwest’s notice of termination of development of a Specified Compound under Section 2.3.4 until Edison’s presentation to Penwest of an ESC as a Replacement Compound pursuant to Section 2.3.4.
Sample 1
AutoNDA by SimpleDocs

Related to Presentation of ESC

  • Representation of Executive Executive represents and warrants to Employer that Executive is free to enter into this Agreement and has no contract, commitment, arrangement or understanding to or with any party that restrains or is in conflict with Executive’s performance of the covenants, services and duties provided for in this Agreement, and is not contravene the terms of any statute, law, or regulation to which Executive is subject. Executive agrees to indemnify Employer and to hold it harmless against any and all liabilities or claims arising out of any unauthorized act or acts by Executive that, the foregoing representation and warranty to the contrary notwithstanding, are in violation, or constitute a breach, of any such contract, commitment, arrangement or understanding.

  • Representation of Employee Employee represents and warrants to Convergent that Employee is free to enter into this Agreement and that has no commitment, arrangement, or understanding to or with any party that restrains or is in conflict with Employee's performance of this Agreement.

  • Company Representation Company represents and warrants that it has no obligation which would prohibit it from entering into this Agreement or complying with its provisions and that it has the authority to enter into this Agreement.

  • Basic Representations Section 3(a) of the Agreement is hereby amended by the deletion of “and” at the end of Section 3(a)(iv); the substitution of a semicolon for the period at the end of Section 3(a)(v) and the addition of Sections 3(a)(vi), as follows:

  • Applicants' Representations 1. Each of the Funds is registered under the 1940 Act as an open-end management investment company and was organized as a Massachusetts business trust. The Templeton Trust currently consists of eight separate series, and the VIP Trust consists of twenty-five separate series. Each Fund's Declaration of Trust permits the Trustees to create additional series of shares at any time. The Funds currently serve as the underlying investment medium for variable annuity contracts and variable life insurance policies issued by various insurance companies. The Funds have entered into investment management agreements with certain investment managers ("Investment Managers") directly or indirectly owned by Franklin Resources, Inc. ("Resources"), a publicly owned company engaged in the financial services industry through its subsidiaries.

  • Company Representations The Company represents and warrants to the Purchaser that:

  • Independent Representation Each party hereto acknowledges and agrees that it has received or has had the opportunity to receive independent legal counsel of its own choice and that it has been sufficiently apprised of its rights and responsibilities with regard to the substance of this Agreement.

  • Joint Representations Each party represents and warrants, which representations and warranties shall be deemed to be continuing throughout the term of this Agreement, that:

  • Legal Representation of Parties The Loan Documents were negotiated by the parties with the benefit of legal representation and any rule of construction or interpretation otherwise requiring this Agreement or any other Loan Document to be construed or interpreted against any party shall not apply to any construction or interpretation hereof or thereof.

  • Additional Representation Section 3 is amended by the addition at the end thereof of the following additional representations (provided that the representation in Section 3(h) will be made by Party A only):

Time is Money Join Law Insider Premium to draft better contracts faster.